StemCells (STEM) announces plans to sell more common stock and warrants in an effort to raise...


StemCells (STEM) announces plans to sell more common stock and warrants in an effort to raise funds for product development. The offer comes as a surprise to investors, considering the company effected a 1-for-10 reverse stock split earlier this year as part of an effort to meet Nasdaq listing rules and increase the shares' appeal to investors. Shares -10.7% AH.

Comments (1)
  • Gary Jakacky
    , contributor
    Comments (2949) | Send Message
     
    Typical 'sexy' medical technology stock...good at selling shares, but when it comes to selling PRODUCTS..well...uh...... Obama can force people to buy our stuff! YEAH!
    15 Dec 2011, 07:42 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs